Literature DB >> 6156063

Serum alpha-fetoprotein in patients following partial hepatectomy.

N Nagasue, K Inokuchi, M Kobayashi, R Kanashima.   

Abstract

Serum alpha-fetoprotein (AFP) concentrations were estimated postoperatively at weekly intervals with the radioimmunoassay in eight adult patients. Seven patients underwent partial hepatectomies of up to 80% of the liver. Surgical drainage was carried out in one individual who had a huge pyogenic abscess in the right hepatic lobe. Despite evidence of clinical and biochemical recovery associated with normal liver regeneration, none of the sera were positive for AFP during the period 4-12 weeks after operation. This study does not support the hypothesis that the elevation of serum AFP in benign liver diseases reflects the extent of liver regeneration.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6156063     DOI: 10.1007/BF01308512

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Alpha-fetoprotein in acute viral hepatitis.

Authors:  T Akeyama; T Koyama; T Kamada
Journal:  N Engl J Med       Date:  1972-11-09       Impact factor: 91.245

2.  Alpha-1 fetoglobulin in the diagnosis of human hepatoma.

Authors:  M E Alpert; J Uriel; B de Nechaud
Journal:  N Engl J Med       Date:  1968-05-02       Impact factor: 91.245

3.  Embryonal serum alpha-globulin in cancer patients: diagnostic value.

Authors:  G I Abelev; I V Assecritova; N A Kraevsky; S D Perova; N I Perevodchikova
Journal:  Int J Cancer       Date:  1967-09-15       Impact factor: 7.396

4.  Occurrence of alpha-fetoprotein in acute viral hepatitis.

Authors:  J B Smith
Journal:  Int J Cancer       Date:  1971-11-15       Impact factor: 7.396

5.  Different mechanisms of increased alpha-fetoprotein production in rats following CCl4 intoxication and partial hepatectomy.

Authors:  K Taketa; A Watanabe; K Kosaka
Journal:  Ann N Y Acad Sci       Date:  1975-08-22       Impact factor: 5.691

6.  AFP-producing cells in hepatitis and in liver cirrhosis.

Authors:  S Sakamoto; A Yachi; T Anzai; T Wada
Journal:  Ann N Y Acad Sci       Date:  1975-08-22       Impact factor: 5.691

7.  Alpha-fetoprotein concentrations measured by radioimmunoassay in diagnosing and excluding hepatocellular carcinoma.

Authors:  P J Johnson; B Portmann; R Williams
Journal:  Br Med J       Date:  1978-09-02

8.  Prognostic value of serum alpha-fetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion.

Authors:  I M Murray-Lyon; A H Orr; B Gazzard; J Kohn; R Williams
Journal:  Gut       Date:  1976-08       Impact factor: 23.059

9.  Serum alpha-fetoprotein in patients with massive hepatic necrosis.

Authors:  J R Bloomer; T A Waldmann; K R McIntire; G Klatskin
Journal:  Gastroenterology       Date:  1977-03       Impact factor: 22.682

10.  Alpha-fetoprotein (AFP) in benign liver disease. Evidence that normal liver regeneration does not induce AFP synthesis.

Authors:  E Alpert; E R Feller
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682

View more
  3 in total

1.  Human liver regeneration after major hepatic resection. A study of normal liver and livers with chronic hepatitis and cirrhosis.

Authors:  N Nagasue; H Yukaya; Y Ogawa; H Kohno; T Nakamura
Journal:  Ann Surg       Date:  1987-07       Impact factor: 12.969

2.  Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma.

Authors:  Xin-Sen Xu; Kai Qu; Chang Liu; Yue-Lang Zhang; Jun Liu; Yan-Zhou Song; Peng Zhang; Si-Nan Liu; Hu-Lin Chang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

3.  Circulating intercellular adhesion molecule 1 predicts non-specific elevation of alpha 1-fetoprotein.

Authors:  E Falleti; C Fabris; M Pirisi; G Soardo; D Vitulli; P Toniutto; E Bartoli; N Bortolotti; F Gonano
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.